Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Elevated serum ApoE levels are associated with bacterial infections in pediatric patients.

Fu P, Wang AM, He LY, Song JM, Xue JC, Wang CQ.

J Microbiol Immunol Infect. 2014 Apr;47(2):122-9. doi: 10.1016/j.jmii.2013.05.010. Epub 2013 Aug 7.

PMID:
23932367
[PubMed - indexed for MEDLINE]
2.

The diagnostic value of apolipoprotein E in pediatric patients with invasive bacterial infections.

Wang C, Wang Y, Wang A, Fu P, Yang Y.

Clin Biochem. 2012 Feb;45(3):215-8. doi: 10.1016/j.clinbiochem.2011.11.009. Epub 2011 Dec 2.

PMID:
22178110
[PubMed - indexed for MEDLINE]
3.

Serum apolipoprotein E as a marker to monitor graft function after hepatocyte transplantation in a clinically relevant mouse model.

Jorns C, Takahashi T, Callaghan E, Zemack H, Larsson L, Nowak G, Parini P, Ericzon BG, Ellis E.

Transplant Proc. 2013 Jun;45(5):1780-6. doi: 10.1016/j.transproceed.2013.01.032.

PMID:
23769043
[PubMed - indexed for MEDLINE]
4.
5.

Heparin protects against septic mortality via apoE-antagonism.

Chuang KI, Leung B, Hsu N, Harris HW.

Am J Surg. 2011 Sep;202(3):325-35. doi: 10.1016/j.amjsurg.2010.10.017. Epub 2011 Jul 8.

PMID:
21741028
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Serum amyloid A and lipoprotein retention in murine models of atherosclerosis.

O'Brien KD, McDonald TO, Kunjathoor V, Eng K, Knopp EA, Lewis K, Lopez R, Kirk EA, Chait A, Wight TN, deBeer FC, LeBoeuf RC.

Arterioscler Thromb Vasc Biol. 2005 Apr;25(4):785-90. Epub 2005 Feb 3.

PMID:
15692094
[PubMed - indexed for MEDLINE]
Free Article
7.

[Expression profiles of lipid metabolism-related genes in liver of apoE(-/-)/LDLR(-/-) mice].

Du HQ, Yin M, Ye HY, Shang YJ, Dai XD, Jing W, Zhang L, Xiao N, Li JF, Pan J.

Zhonghua Bing Li Xue Za Zhi. 2007 Nov;36(11):751-5. Chinese.

PMID:
18307880
[PubMed - indexed for MEDLINE]
8.
9.

A protective role for kidney apolipoprotein E. Regulation of mesangial cell proliferation and matrix expansion.

Chen G, Paka L, Kako Y, Singhal P, Duan W, Pillarisetti S.

J Biol Chem. 2001 Dec 28;276(52):49142-7. Epub 2001 Sep 28.

PMID:
11579084
[PubMed - indexed for MEDLINE]
Free Article
10.

Cardiac troponin T content in heart and skeletal muscle and in blood samples from ApoE/LDL receptor double knockout mice.

Löwbeer C, Forsberg AM, Tokuno S, Hemdahl AL, Gustafsson SA, Valen G.

Clin Chim Acta. 2004 Jun;344(1-2):73-8.

PMID:
15149873
[PubMed - indexed for MEDLINE]
11.

In the absence of endogenous mouse apolipoprotein E, apolipoprotein E*2(Arg-158 --> Cys) transgenic mice develop more severe hyperlipoproteinemia than apolipoprotein E*3-Leiden transgenic mice.

van Vlijmen BJ, van Dijk KW, van't Hof HB, van Gorp PJ, van der Zee A, van der Boom H, Breuer ML, Hofker MH, Havekes LM.

J Biol Chem. 1996 Nov 29;271(48):30595-602.

PMID:
8940032
[PubMed - indexed for MEDLINE]
Free Article
12.

Infection induces a positive acute phase apolipoprotein E response from a negative acute phase gene: role of hepatic LDL receptors.

Li L, Thompson PA, Kitchens RL.

J Lipid Res. 2008 Aug;49(8):1782-93. doi: 10.1194/jlr.M800172-JLR200. Epub 2008 May 22.

PMID:
18497424
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Low and high density lipoprotein metabolism in primary cultures of hepatic cells from normal and apolipoprotein E knockout mice.

Auger A, Truong TQ, Rhainds D, Lapointe J, Letarte F, Brissette L.

Eur J Biochem. 2001 Apr;268(8):2322-30.

PMID:
11298750
[PubMed - indexed for MEDLINE]
Free Article
14.

Hyperlipidemia of ApoE2(Arg(158)-Cys) and ApoE3-Leiden transgenic mice is modulated predominantly by LDL receptor expression.

van Dijk KW, van Vlijmen BJ, de Winther MP, van 't Hof B, van der Zee A, van der Boom H, Havekes LM, Hofker MH.

Arterioscler Thromb Vasc Biol. 1999 Dec;19(12):2945-51.

PMID:
10591674
[PubMed - indexed for MEDLINE]
Free Article
15.

Hepatic low-density lipoprotein receptor-related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol.

Espirito Santo SM, Pires NM, Boesten LS, Gerritsen G, Bovenschen N, van Dijk KW, Jukema JW, Princen HM, Bensadoun A, Li WP, Herz J, Havekes LM, van Vlijmen BJ.

Blood. 2004 May 15;103(10):3777-82. Epub 2004 Jan 22.

PMID:
14739216
[PubMed - indexed for MEDLINE]
Free Article
16.

Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells.

Ji ZS, Brecht WJ, Miranda RD, Hussain MM, Innerarity TL, Mahley RW.

J Biol Chem. 1993 May 15;268(14):10160-7.

PMID:
7683668
[PubMed - indexed for MEDLINE]
Free Article
17.

Essential role for the (hepatic) LDL receptor in macrophage apolipoprotein E-induced reduction in serum cholesterol levels and atherosclerosis.

Van Eck M, Van Dijk KW, Herijgers N, Hofker MH, Groot PH, Van Berkel TJ.

Atherosclerosis. 2001 Jan;154(1):103-12.

PMID:
11137088
[PubMed - indexed for MEDLINE]
18.

Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia.

Ji ZS, Fazio S, Mahley RW.

J Biol Chem. 1994 May 6;269(18):13421-8.

PMID:
8175773
[PubMed - indexed for MEDLINE]
Free Article
19.

The hypolipidemic effect of cilostazol can be mediated by regulation of hepatic low-density lipoprotein receptor-related protein 1 (LRP1) expression.

Kim HJ, Moon JH, Kim HM, Yun MR, Jeon BH, Lee B, Kang ES, Lee HC, Cha BS.

Metabolism. 2014 Jan;63(1):112-9. doi: 10.1016/j.metabol.2013.09.006. Epub 2013 Oct 17.

PMID:
24139096
[PubMed - indexed for MEDLINE]
20.

Role of apolipoprotein E receptors in regulating the differential in vivo neurotrophic effects of apolipoprotein E.

Veinbergs I, Van Uden E, Mallory M, Alford M, McGiffert C, DeTeresa R, Orlando R, Masliah E.

Exp Neurol. 2001 Jul;170(1):15-26.

PMID:
11421580
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk